Tag Archive for: Lonza AG

Neurosense Therapeutics targets Alzheimer's and Parkinson's Disease but is most advanced in ALS. © Neurosense Therapeutics Ltd
Collaboration

Lonza AG enters R&D collaboration with NeuroSense Therapeutics Ltd

ALS specialist NeuroSense Therapeutics Ltd announces it will be collaborating with Swiss Lonza AG to identify exosome-based biomarkers to advance theranostics in neurodegeneration.

Read more